| CTRI Number |
CTRI/2024/07/071502 [Registered on: 29/07/2024] Trial Registered Prospectively |
| Last Modified On: |
23/07/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
To evaluate effect of daruharidra arka in the management of dry eye syndrome |
|
Scientific Title of Study
|
Effect of daruharidra arka in the management of dry eye syndrome- a randomized control trial |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Vignesh Sen |
| Designation |
Pg Scholar |
| Affiliation |
Amrita vishwa vidyapeetham |
| Address |
Department of rasasastra and bhaishajya kalpana,
Amrita school of ayurveda
Amritapuri, Clappana po
Kollam
Kollam KERALA 690525 India |
| Phone |
8921769438 |
| Fax |
|
| Email |
vigneshsen77@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Vineeth P K |
| Designation |
Associate Professor, Department of rasasastra and bhaishajya kalpana |
| Affiliation |
Amrita vishwa vidyapeetham |
| Address |
Department of rasasastra and bhaishajya kalpana,
Amrita school of ayurveda
Amritapuri, Clappana po
Kollam
Kollam KERALA 690525 India |
| Phone |
8547483357 |
| Fax |
|
| Email |
dr.vineethpk@ay.amrita.edu |
|
Details of Contact Person Public Query
|
| Name |
Dr Vineeth PK |
| Designation |
Associate Professor, Department of rasasastra and bhaishajya kalpana |
| Affiliation |
Amrita vishwa vidyapeetham |
| Address |
Amrita school of ayurveda
Amritapuri, Clappana po
Kollam,Kerala,India- 690525
Kollam KERALA 690525 India |
| Phone |
8547483357 |
| Fax |
|
| Email |
dr.vineethpk@ay.amrita.edu |
|
|
Source of Monetary or Material Support
|
| Amrita school of ayurveda
Amrita vishwa vidyapeetham,Amritapuri campus, Clappana PO Kollam-690525,Kerala,India |
|
|
Primary Sponsor
|
| Name |
Dr Vignesh Sen |
| Address |
Amrita school of ayurveda
Amrita vishwa vidyapeetham,Amritapuri campus, Clappana PO Kollam-690525,Kerala,India |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Vignesh Sen |
Amrita School Of Ayurveda |
Department of rasasastra and bhaishajya kalpana
Amrita school of ayurveda
Amritapuri, Clappana po
Kollam, Kerala, 690525 Kollam KERALA |
8921769438
vigneshsen77@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| IEC Amrita School Of Ayurveda |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:H048||Other disorders of lacrimal system. Ayurveda Condition: SUSHKAKSHIPAKAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Procedure | - | AScyotanam, आशà¥à¤šà¥à¤¯à¥‹à¤¤à¤¨à¤®à¥ | (Procedure Reference: Susrutha (Su.U. 18/45-46), Procedure details: (2 drops) two times a day for a duration of one month
) (1) Medicine Name: Daruharidra arka, Reference: Arkaprakasha, Route: Ocular, Dosage Form: Arka, Dose: 2(drops), Frequency: bd, Duration: 1 Months | | 2 | Comparator Arm (Non Ayurveda) | | - | Carboxymethylcellulose | 2 drops two times a day for a duration of one month |
|
|
|
Inclusion Criteria
|
| Age From |
21.00 Year(s) |
| Age To |
40.00 Year(s) |
| Gender |
Both |
| Details |
1.Patient having specific symptoms of Dry eye.
2.Schirmer-I test positive (less than 15mm)
3.Tear film break-up time less than 15 seconds
|
|
| ExclusionCriteria |
| Details |
1.Patient with impaired eyelid function (eg: Bell’s palsy)
2.Patients with eyelid deformities
3.Patients with infective eye disease
4.Pregnancy, lactation, patients under corticosteroids
5.Patients on steroids, oral contraceptive pills, estrogen replacement therapy or any other medication that may adversely affect the outcome of the study
6.Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro- Endocrinal disorders, etc.).
|
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
|
Method of Concealment
|
Pre-numbered or coded identical Containers |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
Reduction in pain, sensitivity, Blurred vision
Improvement in schimers test and Tear film breakup time
|
4 weeks and 8 weeks |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Reduces the discomfort in eye |
4 weeks & 8 weeks |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
30/08/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="5" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
SUMMARY OF PROPOSED DISSERTATION
EFFECT OF DARUHARIDRA ARKA IN THE MANAGEMENT OF DRY EYE
SYNDROME - A RANDOMIZED CONTROL TRIAL GUIDE – Dr VINEETH P K, CO- GUIDE – Dr PRAJEESH NATH E N, SCHOLAR – Dr VIGNESH SEN In ophthalmology, Dry Eye Syndrome is a common issue, corresponds to the traditional
Ayurvedic concept of “Sushkakshipakaâ€. This condition is characterized by inadequate tear
production, resulting in a lack of proper lubrication and nourishment for the eyes.Tears play a
vital role in maintaining the cornea’s health and ensuring clear vision. Dry eye is a chronic
concern, especially among the elderly, and is influenced by various factors such as ageing,
medical conditions, medicine side effects, dry climates and increased screen time.In the
previous studies carried out in various countries estimate the prevalence of dry eye disease to
be between 5-34 %, while India is at 29.25%. Despite the vital significance of maintaining
vision and the prevalence of Dry Eye Syndrome, effective treatment solution remains limited.
Traditional Ayurvedic texts provide comprehensive guidance on the management of
Sushkakshipaka. Arka kalpana are mentioned for the management of eye diseases. It has
more shelf life, increased potency, and it is laghupaki, vyavayi and vikasi. Daruharidra arka
used in this study has the properties like chakshushya, netraruja-hara, sodhahara, kanduhara,
ropana.
According to Susruta samhita considered Shushkakshipaka is due to due to excessive
vitiation of vata. And Ashtanga Hridaya has attributed involvement of vata and pitta doshas in
the pathogenesis
In a recent study on dry eye management, Daruharidradi seka shows promising results in
relieving ruksha, toda, raga, and daha. The ushna virya of Daruharidra helps to pacify the
Vata dosha making way for samprapti vighatana and relieving symptoms. Based on this, here
we are using Daruharidra arka in the management of dry eye.
Carboxymethylcellulose eye drops is taken as the control group in this study.
The clinical study will be carried out in 40 patients (20 patients in two groups by lot or chit
method) with signs and symptoms of Dry Eye Syndrome who fulfil inclusion criteria
belonging to either sex from OPD and IPD of Amrita School of Ayurveda
Clinical assessment is done using subjective parameter Ocular Surface Disease Index (OSDI)
Questionnaire. And Objective Parameters is done using Tear film break up time,Schirmer test
1
Consent will be taken in their own language before treatment. Subjective and objective
parameters will be assessed and recorded in CRF.
To group A Aschyotana is done with Daruharidra arka (3 drops) two times a day for a
duration of one month. For group B Aschyotana is done with Carboxymethylcellulose eye
drops (3 drops) two times a day for a duration of one month. After treatment both subjective
and objective parameters will be assessed and recorded. Follow on 15th day after the
treatment to assess the sustained effect of the treatment. The data obtained will be tabulated
and statistically analysed using Wilcoxon signed rank test and Paired-t-test |